Here are four points:
1. The device is indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2 to S1.
2. The device, developed Camber Spine Technologies, is designed to be used with additional FDA-cleared supplementary fixation systems.
3. Dr. Gleimer implanted the device in a two-level lumbar procedure at levels L4/L5 and L5/S1 at Kennedy University Hospital-Washington Township in Turnersville, N.J.
4. Dr. Gleimer practices with Cherry Hill, N.J.-based Regional Orthopedic Professional Association. He completed spine surgery fellowship training at the Southern California Orthopedic Institute in Van Nuys, Calif.
More articles on devices:
Zimmer Biomet celebrates 40 years of Oxford Partial Knee System use: 4 key takeaways
OrthoPediatrics releases PediLoc Infant LPF Plating System: 4 things to know
Global sports medicine devices market to reach $8.63B by 2020: 3 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
